POST-ACQUISITION INTEGRATION OF SMALL BIOTECHNOLOGY FIRMS

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "POST-ACQUISITION INTEGRATION OF SMALL BIOTECHNOLOGY FIRMS"

Transcription

1 POST-ACQUISITION INTEGRATION OF SMALL BIOTECHNOLOGY FIRMS IN THE STRUCTURE OF LARGE PHARMACEUTICAL COMPANIES Inauguraldissertation zur Erlangung des Grades eines doctor rerum politicarum (Dr. rer. pol.) an der Fakultät Sozial- und Wirtschaftswissenschaften der Otto-Friedrich-Universität Bamberg vorgelegt von Lars Schweizer am 10. Oktober 2001

2 Gutachter: Erstgutachter: Zweitgutachter: Prof. Dr. Dodo zu Knyphausen-Aufseß Prof. Dr. Johann Engelhard Tag der Promotion: 21. Februar 2002 Bamberg: Universität, Diss., 2002

3 Table of contents page 1 Introduction and structure of the research Research methodology Research question and methodology Research design Case studies of organizational integration of biotechnology companies after the M&A deal Building industry context The pharmaceutical industry The biotechnology industry The inevitable need for M&A The case of Pharmacia Corp. - SUGEN, Inc Case description Within-case analysis The case of Merck KGaA - Lexigen Pharmaceuticals Corp Case description Within-case analysis The case of Novartis AG - SyStemix, Inc./Genetic Therapy, Inc Case description Within-case analysis The case of Bayer Diagnostics Corp. - Chiron Diagnostics Corp Case description Within-case analysis Cross-case analyses and building a set of tentative hypotheses Theoretical perspectives of the post-acquisition integration and collaboration process Confronting extant M&A theories with the case findings Confronting extant post-merger literature with the case findings Determination and concepts of the overall integration strategy Discussion of the different organizational integration topics...222

4 Organizational collaboration after the acquisition Aspects of knowledge and competence transfer after the acquisition Cultural issues in the context of the post-acquisition integration strategy Human resources related issues of the post-acquisition integration process Discussion of the organization of the post-acquisition integration process Constructing a new approach and directions for further research Constructing a new approach Implications of core competencies and value chain Constructing a new approach: Framework for the post-acquisition integration of small high-technology companies in the structure of large corporations Revisiting the tentative hypotheses Implications and directions for further research References Summary in German Case study database... (separate volume)

5 List of figures page Figure 1: Performance of mergers... 2 Figure 2: Contributions of pharmaceutical discoveries... 5 Figure 3: Structure of the study Figure 4: Classification matrix for M&A activities in the pharmaceutical and biotechnology industry Figure 5: Research outline of the study about post-acquisition integration activities Figure 6: Research and development process for a new drug Figure 7: Development of research costs in the pharmaceutical industry Figure 8: Earnings pressure and M&A activities in the pharmaceutical industry Figure 9: Transformation process in the pharmaceutical industry Figure 10: Three generations of biotechnology Figure 11: Biotechnology value chain for human health care Figure 12: Potential developments of the interplay between biotechnology and pharmaceutical companies Figure 13: Valuations of mergers and acquisitions involving biotechnology companies Figure 14: M&A activities in the biotechnology and pharmaceutical industry Figure 15: New alliances between pharmaceutical and biotechnology companies Figure 16: Geographic distribution of pharmaceutical partners for biotechnology companies. 68 Figure 17: Gradual consolidation of the biotechnology industry through increased M&A activities Figure 18: The seamless product flow system of Pharmacia Figure 19: Merck s organizational structure Figure 20: History of Lexigen Figure 21: Bayer AG organization Figure 22: Industry-life-cycle-model Figure 23: Trautwein s theories of merger motives Figure 24: Post-merger integration tasks Figure 25: Framework for post-merger integration management Figure 26: Types of acquisition integration approaches Figure 27: Different types of subsidiary strategy Figure 28: Managing innovations in the transnational organization Figure 29: The most commonly used mechanisms of coordination Figure 30: Four generic types of international R&D and innovation Figure 31: Types of corporations and their dominant patterns of innovation Figure 32: Determinants of the rate and direction of firm level innovation Figure 33: Matrix of innovation, capabilities and preferred organizational forms Figure 34: The acquired firm s preferred adaptation process Figure 35: The acquiring firm s preferred adaptation process

6 Figure 36: Common planning model for the integration process Figure 37: Steps of the post-merger process Figure 38: Detailed steps of the post-merger integration process Figure 39: The generic value chain Figure 40: Post-acquisition integration framework

7 List of tables page Table 1: Sample of major M&A deals Table 2: M&A deals valued more than $100 million in Table 3: M&A deals valued more than $100 million in Table 4: M&A deals valued more than $100 million in Table 5: Classified summary of the tentative hypotheses

8 List of acronyms ADR AG AIDS BCG BIO CA CEO CFO CHF Corp. CRO DBF Dipl.-Kfm. DNA e.g. EASDAQ ed. Ed. ELISCO EU FDA GTI HTTP i.e. Inc. IPO KGaA M&A M.B.A. MA MD NAD NASDAQ NBF NC NJ OECD OTA OTC R&D RDNA American depository receipt Aktiengesellschaft [corporation] Acquired Immune Deficiency Syndrome Boston Consulting Group Biotechnology Industry Organization California Chief Executive Officer Chief Financial Officer Swiss Franc Corporation Clinical Research Organization Dedicated Biotechnology Firm Diplom-Kaufmann [Master of Science in Business Administration] Deoxyribonucleic acid for example European association of securities dealers automated quotation Edition Editor Entrepreneurial life science company European Union Food and Drug Administration Genetic Therapy, Inc. Hypertext transport protocol That is Incorporated Initial public offering Kommanditgesellschaft auf Aktien [Limited partnership on shares] Mergers and Acquisitions Master of Business Administration Massachusetts Maryland Nucleic Acid Diagnostic National association of securities dealers automated quotation New Biotechnology Firm North Carolina New Jersey Organization for Economic Cooperation and Development Office of Technology Assessment Over-the-counter Research and Development Recombinant deoxyribonucleic acid

9 S.A. SEC SIC U.K. U.S. VFA Vol. VP WWW Société Anonyme [corporation] Security and Exchange Commission Standard Industrial Classification United Kingdom United States Verband Forschender Arzneimittelhersteller e.v. Volume Vice President world wide web

POST-ACQUISITION INTEGRATION OF SMALL BIOTECHNOLOGY FIRMS

POST-ACQUISITION INTEGRATION OF SMALL BIOTECHNOLOGY FIRMS POST-ACQUISITION INTEGRATION OF SMALL BIOTECHNOLOGY FIRMS IN THE STRUCTURE OF LARGE PHARMACEUTICAL COMPANIES Inauguraldissertation zur Erlangung des Grades eines doctor rerum politicarum (Dr. rer. pol.)

More information

Customer Intimacy Analytics

Customer Intimacy Analytics Customer Intimacy Analytics Leveraging Operational Data to Assess Customer Knowledge and Relationships and to Measure their Business Impact by Francois Habryn Scientific Publishing CUSTOMER INTIMACY ANALYTICS

More information

Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area

Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area Profile of Biomedical Research and Biotechnology Commercialization San Oakland San Jose Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in San The San Bay area is in many

More information

A Mediated Access Control Infrastructure for Dynamic Service Selection

A Mediated Access Control Infrastructure for Dynamic Service Selection A Mediated Access Control Infrastructure for Dynamic Service Selection Dissertation zur Erlangung des Grades eines Doktors der Wirtschaftswissenschaften (Dr. rer. pol.) eingereicht an der Fakultat fur

More information

Multi-Channel Distribution Strategies in the Financial Services Industry

Multi-Channel Distribution Strategies in the Financial Services Industry Multi-Channel Distribution Strategies in the Financial Services Industry DISSERTATION der Universität St. Gallen, Hochschule für Wirtschafts-, Rechts- und Sozialwissenschaften (HSG) zur Erlangung der Würde

More information

EBS Universität für Wirtschaft und Recht EBS Business School. In order to obtain the academic degree of Doctor rerum politicarum (Dr. rer. pol.

EBS Universität für Wirtschaft und Recht EBS Business School. In order to obtain the academic degree of Doctor rerum politicarum (Dr. rer. pol. EBS Universität für Wirtschaft und Recht EBS Business School Inaugural Dissertation In order to obtain the academic degree of Doctor rerum politicarum (Dr. rer. pol.) Supply Chain Integration, Responsive

More information

User Guidance in Business Process Modelling

User Guidance in Business Process Modelling User Guidance in Business Process Modelling Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften vorgelegt von Diplom-Wirtschaftsinformatiker (FH) Matthias Born aus Albstadt genehmigt von

More information

Requirements and Challenges for the Migration from EDIFACT-Invoices to XML-Based Invoices. Master Thesis

Requirements and Challenges for the Migration from EDIFACT-Invoices to XML-Based Invoices. Master Thesis Requirements and Challenges for the Migration from EDIFACT-Invoices to XML-Based Invoices Master Thesis zur Erlangung des akademischen Grades "Master of Science (M.Sc.)" im Studiengang Wirtschaftswissenschaften

More information

Chair of Financial Management

Chair of Financial Management Chair of Financial Management Current Doctoral Theses: Dipl.-Kfm. Markus Brendel (Research associate) Revisiting the causal impact of ownership concentration on firm s performance (Cumulative doctoral

More information

The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry

The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Talentmark Consulting Product Driven People Solutions Press Release The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Cambridge

More information

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical

More information

Susceptibility Weighted Imaging and Quantitative Susceptibility Mapping at 3 Tesla and Beyond

Susceptibility Weighted Imaging and Quantitative Susceptibility Mapping at 3 Tesla and Beyond Susceptibility Weighted Imaging and Quantitative Susceptibility Mapping at 3 Tesla and Beyond New Approaches and Applications DISSERTATION zur Erlangung des akademischen Grades Doktoringenieur (Dr.-Ing.)

More information

J. Melville ( Mel ) Engle, MBA mel@englestrategicsolutions.com DIRECTOR OF THE BOARD

J. Melville ( Mel ) Engle, MBA mel@englestrategicsolutions.com DIRECTOR OF THE BOARD J. Melville ( Mel ) Engle, MBA mel@englestrategicsolutions.com 4152 Casper Way 94558 (707) 312-1822 cell DIRECTOR OF THE BOARD Public/Private Company Director, Lead Independent Director, Chairman of the

More information

Join our scientific talent community

Join our scientific talent community Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into

More information

Privacy-preserving Infrastructure for. Social Identity Management

Privacy-preserving Infrastructure for. Social Identity Management Privacy-preserving Infrastructure for Social Identity Management Dissertation zur Erlangung des Grades eines Doktors der Wirtschaftswissenschaften (Dr. rer. pol.) eingereicht an der Fakultät für Wirtschaftswissenschaften

More information

Characterization of Microemulsions using Small Angle Scattering Techniques

Characterization of Microemulsions using Small Angle Scattering Techniques Characterization of Microemulsions using Small Angle Scattering Techniques Dissertation zur Erlangung des akademischen Grades doctor rerum naturalium (Dr. rer. nat.) vorgelegt der Mathematisch-Naturwissenschaftlich-Technischen

More information

Essays on Enforcement of Accounting Standards, Audit Quality, and Lobbying

Essays on Enforcement of Accounting Standards, Audit Quality, and Lobbying Essays on Enforcement of Accounting Standards, Audit Quality, and Lobbying Inaugural-Dissertation zur Erlangung des Doktorgrades des Fachbereichs Wirtschaftswissenschaften der Johann Wolfgang Goethe-Universitat

More information

Dissertation zur Erlangung des akademischen Grades doctor rerum politicarum. vorgelegt dem Rat der Wirtschaftswissenschaftlichen Fakultät

Dissertation zur Erlangung des akademischen Grades doctor rerum politicarum. vorgelegt dem Rat der Wirtschaftswissenschaftlichen Fakultät VALUE ADDED OF CORPORATE VENTURE CAPITAL: HOW DO CVC UNITS BENEFIT FROM THEIR ORGANIZATIONAL CORE? CASE STUDIES OF THE RELATIONSHIP BETWEEN CVC-UNIT AND BUSINESS UNITS Dissertation zur Erlangung des akademischen

More information

QIAGEN Management Buyout Synthetic DNA Business Unit Conference Call

QIAGEN Management Buyout Synthetic DNA Business Unit Conference Call QIAGEN Management Buyout Synthetic DNA Business Unit Conference Call July 1, 2004 Welcome to QIAGEN s Conference Call Second Management Quarter Buyout and Synthetic Half Year DNA 2003 Business Conference

More information

Twincore - Zentrum für Experimentelle und Klinische Infektionsforschung Institut für Molekulare Bakteriologie

Twincore - Zentrum für Experimentelle und Klinische Infektionsforschung Institut für Molekulare Bakteriologie Twincore - Zentrum für Experimentelle und Klinische Infektionsforschung Institut für Molekulare Bakteriologie 0 HELMHOLTZ I ZENTRUM FÜR INFEKTIONSFORSCHUNG Technische Universität Braunschweig Institut

More information

MYRIAD, HITACHI, ORACLE & FRIEDLI JOIN FORCES TO MAP THE ENTIRE HUMAN PROTEOME

MYRIAD, HITACHI, ORACLE & FRIEDLI JOIN FORCES TO MAP THE ENTIRE HUMAN PROTEOME FOR IMMEDIATE RELEASE MYRIAD, HITACHI, ORACLE & FRIEDLI JOIN FORCES TO MAP THE ENTIRE HUMAN PROTEOME - $185 Million Collaboration to Determine All Human Protein Interactions And Decipher Biochemical Pathways

More information

Targeted Advertising and Consumer Privacy Concerns Experimental Studies in an Internet Context

Targeted Advertising and Consumer Privacy Concerns Experimental Studies in an Internet Context TECHNISCHE UNIVERSITAT MUNCHEN Lehrstuhl fur Betriebswirtschaftslehre - Dienstleistungsund Technologiemarketing Targeted Advertising and Consumer Privacy Concerns Experimental Studies in an Internet Context

More information

Prof. Dr. Kai Förstl

Prof. Dr. Kai Förstl Prof. Dr. Kai Förstl PERSONAL DETAILS Assistant Professor of Global Sourcing EBS Universität für Wirtschaft & Recht EBS Business School Institute for Supply Chain Management Procurement and Logistics (ISCM)

More information

gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) 315-0600 Web gellerbp.

gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) 315-0600 Web gellerbp. gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) 315-0600 Web gellerbp.com Summary Personal Financing LM&A Network Diverse, world-class team

More information

Provider-Independent Social Identity. Management for Personal and. Professional Applications

Provider-Independent Social Identity. Management for Personal and. Professional Applications Provider-Independent Social Identity Management for Personal and Professional Applications Dissertation zur Erlangung des Grades eines Doktors der Wirtschaftswissenschaften eingereicht an der Fakultät

More information

Entrepreneurial spirit and determination to achieve outstanding bottom line and organizational results

Entrepreneurial spirit and determination to achieve outstanding bottom line and organizational results Thom Skinner thom.skinner@sympatico.ca Custom OTHER ACTIVITIES RELATED TO PERSONAL AND PROFESSIONAL DEVELOPMENT Groupe Biscuits Leclerc Inc. FormerDirector and advisor to Chairman PharmaPlus Drug Marts

More information

Corporate Presentation

Corporate Presentation Corporate Presentation Introduction Farmantra is a consulting company specialized in life sciences industry with an initiative to address the gaps in the value chains due to the changing business models

More information

State-Specific Disclosures (AL, CA, CO, CT & FL)

State-Specific Disclosures (AL, CA, CO, CT & FL) State-Specific Disclosures (AL, CA, CO, CT & FL) Alabama 1. Mortgage Loan Origination Agreement (Brokered Loan) 2. Notice of Insurance Choice Disclosure (Lender) California 1. CA Addendum to Loan Application

More information

Buyout and Distressed Private Equity: Performance and Value Creation

Buyout and Distressed Private Equity: Performance and Value Creation TECHNISCHE UNIVERSITAT MUNCHEN Lehrstuhl fur Betriebswirtschaftslehre - Finanzmanagement und Kapitalmarkte (Univ.-Prof. Dr. Christoph Kaserer) Buyout and Distressed Private Equity: Performance and Value

More information

Inspiring Personalities. EBS-Intel Summer School for Social Innovators

Inspiring Personalities. EBS-Intel Summer School for Social Innovators Inspiring Personalities. EBS-Intel Summer School for Social Innovators 2 EBS Executive Education Why Attending? Social Innovators find new solutions to solve social problems. Just think of the microfinance

More information

BIG DATA Driving Evidence for Healthcare Thursday, 5 March 2015 13:30 17:45 Lecture Hall Pathology C

BIG DATA Driving Evidence for Healthcare Thursday, 5 March 2015 13:30 17:45 Lecture Hall Pathology C Symposium of the Swiss-Austrian ISOP Chapter International Society of Pharmacovigilance BIG DATA Driving Evidence for Healthcare Thursday, 5 March 2015 13:30 17:45 Lecture Hall Pathology C Program: Thursday,

More information

IFA-Coding-System Transport Logistics Specification. Automatic identification of transport units in the pharmaceutical supply chain

IFA-Coding-System Transport Logistics Specification. Automatic identification of transport units in the pharmaceutical supply chain IFA-Coding-System Transport Logistics Specification Automatic identification of transport units in the pharmaceutical supply chain Version: 1.00 Date of issue: December 2012 Table of Contents 1 Foreword

More information

Egon Zehnder International

Egon Zehnder International Egon Zehnder I. ID info about yourself Work-setting Preferences Personal Skills Inventory Motivational Factors III. Targeting your employer Narrowing the field Aligning credentials Optimizing documents

More information

BE ON GUARD. Understanding the Executive Liability Risks That Can Threaten Your Biotechnology Company

BE ON GUARD. Understanding the Executive Liability Risks That Can Threaten Your Biotechnology Company Presented by BIO, Monitor Liability Managers, LLC and William Gallagher Associates BE ON GUARD Understanding the Executive Liability Risks That Can Threaten Your Biotechnology Company Serge Adam, AVP Claims

More information

Procurement must be more than just cost cutting

Procurement must be more than just cost cutting Procurement must be more than just cost cutting In today s challenging environment, aggressive cost control has become a common theme in the pharmaceutical industry. It became fashionable later than in

More information

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be

More information

Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry

Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry Tariq Sadat PhD Candidate School of Economics, Finance and Marketing, RMIT University, Australia Roslyn

More information

B8746: Investing in Medical Technologies Fall 2015 (B-Term); Monday 5:45pm 9:00pm

B8746: Investing in Medical Technologies Fall 2015 (B-Term); Monday 5:45pm 9:00pm B8746: Investing in Medical Technologies Fall 2015 (B-Term); Monday 5:45pm 9:00pm Instructor: Office: Email: TA: Email: Efrem Kamen, Founder & Managing Member, Pura Vida Investments, LLC TBD ejk28@columbia.edu

More information

Baxalta 2015 Investor Conference May 19, 2015

Baxalta 2015 Investor Conference May 19, 2015 Eric W. Foster is expected to serve as Senior Vice President and Chief Information Officer for Baxalta upon completion of the separation. Mr. Foster brings more than 15 years of IT leadership experience

More information

Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis

Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Paulina Ramirez: Birmingham Business School IRIMA Workshop on the Internationalisation

More information

Curriculum Vitae. Prof. Dr. Bernhard Kutscher, Ph.D. Personal Details. Education

Curriculum Vitae. Prof. Dr. Bernhard Kutscher, Ph.D. Personal Details. Education Curriculum Vitae Prof. Dr. Bernhard Kutscher, Ph.D. Personal Details Private Address: Date, Place of Birth: Marital Status: Nationality: Languages: Stresemannstraße 9, 93477 Maintal, Germany, Tel. +49

More information

Deals Profiled. M&A Activity. Sector Acquirer Target. In this Issue: M&A Snapshot Information Technology Medical Devices Biotechnology Pharmaceuticals

Deals Profiled. M&A Activity. Sector Acquirer Target. In this Issue: M&A Snapshot Information Technology Medical Devices Biotechnology Pharmaceuticals In this Issue: M&A Snapshot Information Technology Medical Devices Biotechnology Pharmaceuticals Deals Profiled Sector Healthcare-IT Intuit Medfusion Biotechnology PerkinElmer, Inc. Signature Genomics

More information

Names, Addresses and Experience of Directors and Officers

Names, Addresses and Experience of Directors and Officers Page 1 Names, Addresses and Experience of Directors and Officers Woodbury Casino, LLC is wholly owned by Caesars Growth Partners. Caesars Acquisition Company is the managing member of Caesars Growth Partners.

More information

DISCLAIMER: THIS TRANSLATION OF THE

DISCLAIMER: THIS TRANSLATION OF THE DISCLAIMER: THIS TRANSLATION OF THE Promotionsordnung der Wirtschafts- und Sozialwissenschaftlichen Fakultät der Universität zu Köln PUBLISHED IN Amtliche Mitteilungen 8/2008 IS NOT LEGALLY BINDING. Doctoral

More information

AFFITECH and XOMA Sign Antibody Collaboration and Cross-License Agreement

AFFITECH and XOMA Sign Antibody Collaboration and Cross-License Agreement FOR IMMEDIATE RELEASE Ref 05AFF05 Contacts for Affitech: Contacts for XOMA Affitech (Norway): Investor Inquiries Dr. Martin Welschof Ellen M Martin Chief Executive Officer Kureczka/Martin Associates Phone:

More information

Personalized anticancer therapy

Personalized anticancer therapy July 2015 Personalized anticancer therapy Israel R&D : Caesarea Business Park, P.O 4463 Caesarea Israel. U.S Office: #3 Bethesda Metro Center Suite 700 Bethesda, MD. Company overview Cannabics Pharmaceuticals

More information

Life Sciences Outlook. New Jersey 2015

Life Sciences Outlook. New Jersey 2015 Life Sciences Outlook New Jersey 2015 New Jersey M&A activity in New Jersey has led to the consolidation of surplus real estate holdings and diminished head counts. However, midsized companies are helping

More information

Santaravalley: Integrating scientific research, high-tech business and academia Prof. Vladas Algirdas Bumelis President of Santara valley Association Vilnius, Lithuania 2013July 18 th Santara Valley Association

More information

MEDICAL TRANSCRIPTION BILLING, CORP

MEDICAL TRANSCRIPTION BILLING, CORP MEDICAL TRANSCRIPTION BILLING, CORP FORM FWP (Free Writing Prospectus - Filing under Securities Act Rules 163/433) Filed 09/09/15 Address 7 CLYDE ROAD SOMERSET SOMERSET, NJ 08873 Telephone 7328735133 CIK

More information

Implementation Guidelines The SESAMI program of the Graduate School of Business Administration, Kobe University

Implementation Guidelines The SESAMI program of the Graduate School of Business Administration, Kobe University Implementation Guidelines The SESAMI program of the Graduate School of Business Administration, Kobe University 1 Overview These guidelines prescribe the requirements for implementing the Strategic Entrepreneurship

More information

Simon Frei. Profile. Head of Finance. optimization. CFO Finance Organization Reporting. Efficiency improvements. Managing Partner.

Simon Frei. Profile. Head of Finance. optimization. CFO Finance Organization Reporting. Efficiency improvements. Managing Partner. FS Partners AG Bahnhofstrasse 19 CH-9100 Herisau Tel. +41 71 351 1616 Fax. +41 71 351 4140 www.fspartners.ch Profile Simon Frei Managing Partner projects optimization Head of Finance Consulting SAP implementation

More information

for High Performance Computing

for High Performance Computing Technische Universität München Institut für Informatik Lehrstuhl für Rechnertechnik und Rechnerorganisation Automatic Performance Engineering Workflows for High Performance Computing Ventsislav Petkov

More information

Rutgers Mini-MBA : BioPharma Innovation

Rutgers Mini-MBA : BioPharma Innovation Rutgers Mini-MBA : BioPharma Innovation Ga i n t h e s k i l l s to t r a n s f o r m scientific i n n ovat i o n i n to business success www.cmd.rutgers.edu/innovation Rutgers Mini-MBA : BioPharma Innovation

More information

Umbilical Cord Blood Banking System in Virginia. Curtis Thorpe, M.D. Norma Szakal Bryan Stogdale Nicole Seeds Michele Howell

Umbilical Cord Blood Banking System in Virginia. Curtis Thorpe, M.D. Norma Szakal Bryan Stogdale Nicole Seeds Michele Howell Umbilical Cord Blood Banking System in Virginia Curtis Thorpe, M.D. Norma Szakal Bryan Stogdale Nicole Seeds Michele Howell Cord Blood Banking in Virginia Are there any other States or countries that have

More information

EBiSC the first European bank for induced pluripotent stem cells

EBiSC the first European bank for induced pluripotent stem cells Press Release EBiSC the first European bank for induced pluripotent stem cells Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA)

More information

JEFF KAPLAN, PH.D., MBA, MCC

JEFF KAPLAN, PH.D., MBA, MCC JEFF KAPLAN, PH.D., MBA, MCC Dr. Jeff Kaplan has been working in the fields of education and psychology for 25 years. Jeff has spent the majority of the last 15 years coaching, training and consulting.

More information

Pivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform

Pivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform PRESS RELEASE Pivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform Pivot Park Screening Centre in Oss will play an important role in a new pan-european drug

More information

Fachgruppe Drug Delivery

Fachgruppe Drug Delivery industrial career at Beiersdorf-Lilly GmbH, Hamburg Bernd Riebesehl, Ph. D. completed his thesis on solubilization at the TU Braunschweig in 1992. He started his leading a lab for preformulation and line

More information

Biotie Therapies Corp. 4.3.2014

Biotie Therapies Corp. 4.3.2014 1 Biotie Therapies Corp. Corporate Governance Statement 2013 2 CONTENTS 1. Corporate Governance Statement 2. Board of Directors 2.1. Board composition 2.2. The operation of the Board of Directors 2.3.

More information

全 球 多 发 性 硬 化 症 治 疗 市 场 研 究 报 告 Multiple Sclerosis Therapeutics - A Global Strategic Business Report

全 球 多 发 性 硬 化 症 治 疗 市 场 研 究 报 告 Multiple Sclerosis Therapeutics - A Global Strategic Business Report /wepdwukltuyot 全 球 多 发 性 硬 化 症 治 疗 市 场 研 究 报 告 Multiple Sclerosis Therapeutics - A Global Strategic Business Report 联 系 购 买 电 话 :010-82863480 公 司 名 称 : 佐 思 信 息 公 司 地 址 : 北 京 市 海 淀 区 苏 州 街 18 号 院 长 远 天

More information

Notice Regarding Acquisition of Shares in Graphic Controls Holdings, Inc. and Making it a Subsidiary

Notice Regarding Acquisition of Shares in Graphic Controls Holdings, Inc. and Making it a Subsidiary August 5th, 2016 Junya Suzuki President and CEO, Chairman of the Board Nissha Printing Co., Ltd. Exchanges Listed: Tokyo Stock Exchanges, First Section 7915 Contact: Hayato Nishihara Senior Executive Vice

More information

Acquisition of Boston Biomedical Inc. February 29, 2012 Dainippon Sumitomo Pharma Co., Ltd.

Acquisition of Boston Biomedical Inc. February 29, 2012 Dainippon Sumitomo Pharma Co., Ltd. Acquisition of Boston Biomedical Inc. February 29, 2012 Dainippon Sumitomo Pharma Co., Ltd. Oncology Strategy and Acquisition Significance 1 Commitment to Oncology Entering the Oncology Area Globally External

More information

TABLE OF CONTENTS International Transfer Pricing in the Ethical Pharmaceutical Industry Second edition

TABLE OF CONTENTS International Transfer Pricing in the Ethical Pharmaceutical Industry Second edition TABLE OF CONTENTS International Transfer Pricing in the Ethical Pharmaceutical Industry Second edition SUMMARY OF SALIENT POINTS Importance and Competitiveness of the Ethical Pharmaceutical Industry Government

More information

Pharmaceutical Distribution in the US: Current and Future Perspectives

Pharmaceutical Distribution in the US: Current and Future Perspectives Pharmaceutical Distribution in the US: Current and Future Perspectives Publication date: July 2009 Number of pages: 83 Author: Dr Faiz Kermani Pricing: 1,495 (PDF) / 1,550 (print) "In the US, the pharmaceutical

More information

Analysis of Business Models for Electric Vehicles Usage

Analysis of Business Models for Electric Vehicles Usage Analysis of Business Models for Electric Vehicles Usage Bachelorarbeit zur Erlangung des akademischen Grades Bachelor of Science (B.Sc) im Studiengang Wirtschaftswissenschaft der Wirtschaftswissenschaftlichen

More information

Audit committee forum*

Audit committee forum* Ashok Bakhru Chairman of the Board Goldman Sachs Group of Mutual Funds Ashok Bakhru is President of ABN Associates, a management and financial consulting firm working with mid-size firms. Ashok served

More information

European Biotech & Pharma Dr. Patrik Frei May 2014 Tokyo

European Biotech & Pharma Dr. Patrik Frei May 2014 Tokyo European Biotech & Pharma Dr. Patrik Frei May 2014 Tokyo 1 Overview 1. Venture Valuation 2. Trends in the EU Biotech & Pharma 3. Overview European Biotechs / Clusters 2 Valuation Valuation Mission Independent

More information

Satellite-UMTS - Specification of Protocols and Traffic Performance Analysis

Satellite-UMTS - Specification of Protocols and Traffic Performance Analysis Satellite-UMTS - Specification of Protocols and Traffic Performance Analysis Von der Fakultat fur Elektrotechnik und Informationstechnik der Rheinisch-Westfalichen Technischen Hochschule Aachen zur Erlangung

More information

Welcome to CCT Center for Corporate Transactions. December 14, 2012

Welcome to CCT Center for Corporate Transactions. December 14, 2012 Center for Corporate Transactions December 14, 2012 Academic Director Scholarships/Professorships: Prof. Dr. Bernhard Schwetzler CVA bernhard.schwetzler@hhl.de Current position: Chair of Financial Management,

More information

Dr. Anna Maria Schneider

Dr. Anna Maria Schneider Dr. Anna Maria Schneider Postdoctoral Researcher Faculty of Economics and Business Administration Humboldt Universität zu Berlin Rosenstraße 19 10178 Berlin, Germany anna maria.schneider[at]wiwi.hu berlin.de

More information

The understanding of happiness and meaning of life in the concept of human nature of Germans and Peruvians. An empirical cross-cultural comparison

The understanding of happiness and meaning of life in the concept of human nature of Germans and Peruvians. An empirical cross-cultural comparison The understanding of happiness and meaning of life in the concept of human nature of Germans and Peruvians. An empirical cross-cultural comparison Inaugural-Dissertation zur Erlangung des Grades eines

More information

International Strategic Management

International Strategic Management I. Course Contents and Objectives focuses on strategic management in the dynamic global business environment of the 21 st century. Students in this course build the ability to think strategically and better

More information

Global Digital PCR Market Research, PCR Reaction Market Insights, Opportunity, Analysis, Market Shares And Forecast

Global Digital PCR Market Research, PCR Reaction Market Insights, Opportunity, Analysis, Market Shares And Forecast Brochure More information from http://www.researchandmarkets.com/reports/3050459/ Global Digital PCR Market Research, PCR Reaction Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016-2022

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 1Q 2016 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Implementation requirements for knowledge management components into ERP Systems: Comparison of software producers and companies

Implementation requirements for knowledge management components into ERP Systems: Comparison of software producers and companies Implementation requirements for knowledge management components into ERP : Comparison of software producers and companies Bachelorarbeit Zur Erlangung des akademischen Grades Bachelor of Science (B.Sc.)

More information

INTRODUCTION HOW DTCC S MARGIN TRANSIT WILL HELP THE INDUSTRY MANAGE A HIGHER VOLUME OF MARGIN CALLS WHO IS THE MARGIN TRANSIT SERVICE FOR?

INTRODUCTION HOW DTCC S MARGIN TRANSIT WILL HELP THE INDUSTRY MANAGE A HIGHER VOLUME OF MARGIN CALLS WHO IS THE MARGIN TRANSIT SERVICE FOR? DTCC MARGIN TRANSIT INTRODUCTION Derivatives regulations and new capital and liquidity requirements for financial institutions remain the key drivers of new collateral demands. Recent estimates based

More information

ANUJA GUPTA Assistant Professor Anuja.Gupta@rutgers.edu Tel: (856) 225 6227 July 2014

ANUJA GUPTA Assistant Professor Anuja.Gupta@rutgers.edu Tel: (856) 225 6227 July 2014 ANUJA GUPTA Assistant Professor Anuja.Gupta@rutgers.edu Tel: (856) 225 6227 July 2014 EDUCATION University of Pennsylvania, The Wharton School, Philadelphia, PA PhD in Management, May 2010 Master of Science,

More information

CHEM-E4140 Selectivity 12. Pharma Business

CHEM-E4140 Selectivity 12. Pharma Business CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25

More information

Key Findings. Use this report to... The Top 10 Contract Research Organizations

Key Findings. Use this report to... The Top 10 Contract Research Organizations Key Findings The global CRO industry valued $18bn in 2008, an increase of 14% over 2007. The CRO market will grow at an annual rate of 14% over the 2009 13 period. Quintiles leads the global CRO market

More information

Pharmaceutical Industry: Research and Development

Pharmaceutical Industry: Research and Development Pharmaceutical Industry: Research and Development Background Pharmacists in industry are employed in a variety of positions. Although practice titles, descriptions, and prerequisites differ by company,

More information

PYROSEQUENCING AB. Interim report January - September 2003

PYROSEQUENCING AB. Interim report January - September 2003 1 PYROSEQUENCING AB Interim report January - September 2003 Uppsala, Sweden, October 23, 2003. Pyrosequencing AB (Stockholm: PYRO A) today reported results for the first nine months 2003. Highlights (Figures

More information

Development of a Portal for HR Executives to Enable Digital Personnel Files

Development of a Portal for HR Executives to Enable Digital Personnel Files Development of a Portal for HR Executives to Enable Digital Personnel Files Masterarbeit zur Erlangung des akademischen Grades Master of Science (M.Sc.) im Studiengang Wirtschaftswissenschaft der Wirtschaftswissenschaftlichen

More information

Telomerase Reverse Transcriptase Promoter Mutations in Melanoma, Non-Melanoma Skin Cancer and Glioma

Telomerase Reverse Transcriptase Promoter Mutations in Melanoma, Non-Melanoma Skin Cancer and Glioma Aus dem Deutschen Krebsforschungszentrum Heidelberg (Geschaftsfuhrender Direktor: Prof. Dr. Dr. h.c. Otmar D. Wiestler) Forschungsschwerpunkt Krebsriskofaktoren und Prevention Abteilung fur Molekulargenetische

More information

First Quarter 2015 Earnings Teleconference. April 28, 2015

First Quarter 2015 Earnings Teleconference. April 28, 2015 First Quarter 2015 Earnings Teleconference April 28, 2015 Introduction Chuck Triano Senior Vice President, Investor Relations Forward-Looking Statements and Non-GAAP Financial Information Our discussions

More information

Molecular Biology. Master s degree program. Faculty of Science UNI INFO 2015

Molecular Biology. Master s degree program. Faculty of Science UNI INFO 2015 Faculty of Science UNI INFO 2015 Molecular Biology Master s degree program Master of Science: M Sc in Molecular Biology Curriculum This Master s degree program is offered by the Biozentrum of the University

More information

EXIQON TO ACQUIRE ONCOTECH INC AND ENTER THE MARKET FOR CANCER MOLECULAR DIAGNOSTICS IN 2008

EXIQON TO ACQUIRE ONCOTECH INC AND ENTER THE MARKET FOR CANCER MOLECULAR DIAGNOSTICS IN 2008 Announcement no. 22/2007 To OMX The Nordic Exchange, Copenhagen, and the press Vedbæk, November 27, 2007 EXIQON TO ACQUIRE ONCOTECH INC AND ENTER THE MARKET FOR CANCER MOLECULAR DIAGNOSTICS IN 2008 Summary:

More information

Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota 55403 612.202.6805 shaecker@celltherapygroup.com

Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota 55403 612.202.6805 shaecker@celltherapygroup.com Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota 55403 612.202.6805 shaecker@celltherapygroup.com PROFILE Successful Senior Executive, skilled in Corporate Development including Business

More information

OPKO Health to Acquire Bio-Reference Laboratories

OPKO Health to Acquire Bio-Reference Laboratories OPKO Health to Acquire Bio-Reference Laboratories - Complementary in-depth expertise in diagnostics business with state of the art experience in use of genomic data for personalized therapy - Acquisition

More information

ACCOUNTING AND FINANCE

ACCOUNTING AND FINANCE LIVERPOOL HOPE UNIVERSITY FACULTY OF ARTS AND HUMANITIES ACCOUNTING AND FINANCE YOUR FUTURE STARTS WITH HOPE 030815 Accounting and Finance Fact File Faculty: Arts and Humanities Department: Business School

More information

The Biotechnology Program at Montgomery College

The Biotechnology Program at Montgomery College The Biotechnology Program at Montgomery College www.montgomerycollege.edu/biotech Presented by Dr. Sanjay Rai Interim Vice President and Provost Germantown Campus Montgomery College Biotechnology Meeting

More information

Knight Trading Group Reports 16% Growth In Quarterly Earnings and 23% Growth In Quarterly Revenues O

Knight Trading Group Reports 16% Growth In Quarterly Earnings and 23% Growth In Quarterly Revenues O KCG Announcements July 19, 2000 Knight Trading Group Reports 16% Growth In Quarterly Earnings and 23% Growth In Quarterly Revenues O JERSEY CITY, N.J., July 19 /PRNewswire/ -- Knight Trading Group, Inc.

More information

Clinical Research Innovation through Shared Clinical Data Warehousing

Clinical Research Innovation through Shared Clinical Data Warehousing Clinical Research Innovation through Shared Clinical Data Warehousing Jerry Whaley Pfizer Jerry Whaley is senior director of development business technology at Pfizer and is involved in the implementation

More information

CONVERTING YOUR RESUME TO A CURRICULUM VITAE

CONVERTING YOUR RESUME TO A CURRICULUM VITAE CONVERTING YOUR RESUME TO A CURRICULUM VITAE June 2008 CONVERTING YOUR RESUME TO A CURRICULUM VITAE AND VICE VERSA What is the main difference between a CV and a Resume? A resume is a marketing tool a

More information

improving lives through collaborative medicine

improving lives through collaborative medicine improving lives through collaborative medicine ImproveCareNow is a collaborative chronic care network of 77 care centers in 35 states and the District of Columbia and England, where clinicians, researchers,

More information

f ( e z c s e y c n e i i s d t s i s e m H a Autor

f ( e z c s e y c n e i i s d t s i s e m H a Autor or f e c n e i c s ) lied p M p H a F f ( o s e y t s i s sine u b Univers d e z i s ium d e m d n a l smal TO THE WELCOME Autor 1 Facts & Figures Autor 2 Locations of FHM Campus Bielefeld Campus Köln

More information

The Private Health Insurance Market in Europe: Future trends, emerging opportunities and key players

The Private Health Insurance Market in Europe: Future trends, emerging opportunities and key players Brochure More information from http://www.researchandmarkets.com/reports/1232995/ The Private Health Insurance Market in Europe: Future trends, emerging opportunities and key players Description: The dynamics

More information

Trends in IP strategy for young companies viewed from a larger company

Trends in IP strategy for young companies viewed from a larger company Trends in IP strategy for young companies viewed from a larger company Dr David Deperthes Vice President, BD&L, Debiopharm Int. CEO, Debiopharm Diagnostics Agenda General Information on Intellectual Property

More information

Press Release. Tecan reports second quarter consolidated sales of CHF 69.6 million and net profit of CHF 3.9 million

Press Release. Tecan reports second quarter consolidated sales of CHF 69.6 million and net profit of CHF 3.9 million Press Release Tecan reports second quarter consolidated sales of CHF 69.6 million and net profit of CHF 3.9 million Sales for the first six months reach CHF 140.3 million; net profit reaches CHF 9.2 million

More information

ATLAS AIR WORLDWIDE HOLDINGS INC Filed by WELLINGTON MANAGEMENT GROUP LLP

ATLAS AIR WORLDWIDE HOLDINGS INC Filed by WELLINGTON MANAGEMENT GROUP LLP ATLAS AIR WORLDWIDE HOLDINGS INC Filed by WELLINGTON MANAGEMENT GROUP LLP FORM SC 13G (Statement of Ownership) Filed 02/14/14 Address 2000 WESTCHESTER AVENUE PURCHASE, NY 10577-2543 Telephone 9147018000

More information

A Process Model for Data Warehouses Integration to Enable Business Intelligence: An Applicability Check for the Airline Sector.

A Process Model for Data Warehouses Integration to Enable Business Intelligence: An Applicability Check for the Airline Sector. A Process Model for Data Warehouses Integration to Enable Business Intelligence: An Applicability Check for the Airline Sector Bachelorarbeit Zur Erlangung des akademischen Grades Bachelor of Science (B.Sc.)

More information